Work

54147 Efficacy of Ruxolitinib Cream for Treatment of Atopic Dermatitis in Children Aged 2–<12 Years by Baseline Clinical Characteristics: Subgroup Analysis From a Randomized Phase 3 Study (TRuE-AD3)

Year: 2024

Type: article

Source: Journal of the American Academy of Dermatology

DOI: 10.1016/j.jaad.2024.07.792

Authors: April W. Armstrong, Lawrence F. Eichenfield, Lara Wine Lee, Kanwaljit K. Brar, Joel C. Joyce, Seth B. Forman, Weily Soong, Howard Sofen, Brett Angel, Qian Li, Linda F. Stein Gold

Institutions: University of California, Los Angeles, University of California San Diego, Medical University of South Carolina, NYU Langone Health, New York University, Endeavor Health, Incyte (United States), Henry Ford Health

Language: English

Topic: Dermatology and Skin Diseases

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4402106862

FWCI:

Cites:

Cited by:

Related to: 10